TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Kissei Pharmaceutical
Curated by PDSP Ki Database
Kissei Pharmaceutical
Curated by PDSP Ki Database
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
Kissei Pharmaceutical
Curated by PDSP Ki Database
Kissei Pharmaceutical
Curated by PDSP Ki Database
Affinity DataIC50: 4nMAssay Description:Antagonist activity at CRF1 receptor in human IMR32 cells assessed as inhibition of CRF-induced intracellular cAMP accumulation after 30 mins by immu...More data for this Ligand-Target Pair
Affinity DataIC50: 7.10nMAssay Description:Antagonist activity at CRF1 receptor in human IMR32 cells assessed as inhibition of CRF-induced intracellular cAMP accumulation after 30 mins by immu...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Pharmadesign
Curated by ChEMBL
Pharmadesign
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assayMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Pharmadesign
Curated by ChEMBL
Pharmadesign
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assayMore data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Pharmadesign
Curated by ChEMBL
Pharmadesign
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-induced intracellular cAMP production preincubated...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-induced intracellular cAMP production preincubated...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-stimulated intracellular cAMP accumulation after 3...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-stimulated intracellular cAMP accumulation after 3...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-induced intracellular cAMP production preincubated...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-induced intracellular cAMP production preincubated...More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-induced intracellular cAMP production preincubated...More data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 39nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 39nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Displacement of [125I]CRF from human CRF1 receptor expressed in HEK293 cells after 2 hrs by scintillation proximity assayMore data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-induced intracellular cAMP production preincubated...More data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-stimulated intracellular cAMP accumulation after 3...More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-induced intracellular cAMP production preincubated...More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:Antagonist activity at human CRF1 receptor expressed in HEK293 cells assessed as inhibition of CRF-stimulated intracellular cAMP accumulation after 3...More data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:Displacement of [125I]CRF from human CRF1 receptor expressed in HEK293 cells after 2 hrs by scintillation proximity assayMore data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:Displacement of [125I]CRF from human CRF1 receptor expressed in HEK293 cells after 2 hrs by scintillation proximity assayMore data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:A binding competition experiment with CRF was conducted by the SPA (GE Healthcare) method using a 96-well plate.More data for this Ligand-Target Pair